𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Invasive fungal disease in patients treated for newly diagnosed acute leukemia

✍ Scribed by Sarah P. Hammond; Francisco M. Marty; Julie M. Bryar; Daniel J. DeAngelo; Lindsey R. Baden

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
98 KB
Volume
85
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sequential mitoxantrone, daunorubicin, a
Sequential mitoxantrone, daunorubicin, and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia
✍ Paciucci, Paolo Alberto; Cuttner, Janet; Gottlieb, Arlan; Davis, Roger B.; Marte πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 27 KB πŸ‘ 1 views

Mitoxantrone (M) is a synthetic aminoanthraquinone with anti-leukemic activity in patients with daunorubicin (D) resistant acute leukemia. The Cancer and Leukemia Group B (CALGB) has undertaken a limited access pilot study in which M, 12 mg/m2, over 30 min, daily for 3 days, and cytosine arabinoside

Long-term follow-up of patients with new
Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M. D. Anderson Cancer Center
✍ Elihu Estey; Marcos deLima; Sara Strom; Sherry Pierce; Emil J Freireich; Michael πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

## RESULTS. Because failure rates declined to relatively low levels after a first or later complete remission of Β’3 years' duration, such patients comprised a ''potentially Departments of Hematology and Epidemiology, cured'' cohort. The criterion for entry into this cohort was fulfilled by 215 pat

Emergence of secondary acute leukemia in
Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations
✍ Panizo, Carlos; PatiΓ±o, Ana; Calasanz, JosΓ©; RifΓ³n, JosΓ©; Sierrasesumaga, Luis; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

Background. Secondary leukemia and myelodysplastic syndromes have been reported in patients following treatment for a wide range of neoplastic disorders. However, second malignancies after chemotherapy and/or irradiation for osteosarcoma are unusual. Procedure. We report the case of a 15-yearold gi